An even milder impairment of Leydig cell function, characterized by unvaried serum testosterone levels but increased LH - a clinical condition named subclinical hypogonadism - has been associated with a higher risk of hypovitaminosis D, secondary hyperparathyroidism and osteoporosis [25–31]. This evidence concerns the gene PLOD1 and hypogonadism.